CRI Office Hour : Monday - Friday, 09.00 - 17.00
+66 2553 8555
+66 2553 8527
CRI Office Hour : Monday - Friday, 09.00 - 17.00
+66 2553 8555
+66 2553 8527
To find the 2nd edition, type "2nd edition"
Home Publications Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways
Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways
Lertsuwan J, Svasti S, Satayavivad J
Anticancer Res. 2026;46(3):1449-1460.
We use cookies to improve performance. and good experience using your website. You can study details at Cookies policy and can manage your own privacy by clicking on Settings
You can choose your cookie settings by turning them on/off. Cookies of each category are available on request, except essential cookies.
Allow AllNecessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.